New hope for skin cancer
A team from Moderna and Merck has developed a new vaccine based on mRNA technology to combat melanoma, the most dangerous type of skin cancer. Unlike preventive vaccines, this is a personalized treatment given to those already affected by the disease, and it is currently in advanced stages of clinical trials. The goal of the vaccine is to improve treatment outcomes and enhance the prognosis for patients with melanoma.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)